CONMED Corporation (NASDAQ: CNMD) and Orthofix International N.V. (NASDAQ:OFIX) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, analyst recommendations, risk, institutional ownership, dividends, valuation and earnings.
CONMED Corporation pays an annual dividend of $0.80 per share and has a dividend yield of 1.5%. Orthofix International N.V. does not pay a dividend. CONMED Corporation pays out 142.9% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.
Insider and Institutional Ownership
98.3% of CONMED Corporation shares are held by institutional investors. Comparatively, 96.2% of Orthofix International N.V. shares are held by institutional investors. 2.6% of CONMED Corporation shares are held by company insiders. Comparatively, 5.6% of Orthofix International N.V. shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
This table compares CONMED Corporation and Orthofix International N.V.’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Orthofix International N.V.||1.88%||9.96%||7.32%|
Volatility & Risk
CONMED Corporation has a beta of 0.68, suggesting that its share price is 32% less volatile than the S&P 500. Comparatively, Orthofix International N.V. has a beta of 0.2, suggesting that its share price is 80% less volatile than the S&P 500.
This is a breakdown of current ratings and price targets for CONMED Corporation and Orthofix International N.V., as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Orthofix International N.V.||0||0||5||0||3.00|
CONMED Corporation presently has a consensus price target of $49.33, indicating a potential downside of 6.01%. Orthofix International N.V. has a consensus price target of $52.50, indicating a potential upside of 7.60%. Given Orthofix International N.V.’s stronger consensus rating and higher possible upside, analysts plainly believe Orthofix International N.V. is more favorable than CONMED Corporation.
Earnings & Valuation
This table compares CONMED Corporation and Orthofix International N.V.’s gross revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||EBITDA||Earnings Per Share||Price/Earnings Ratio|
|CONMED Corporation||$772.61 million||1.90||$123.91 million||$0.56||93.73|
|Orthofix International N.V.||$418.71 million||2.12||$45.74 million||$0.42||116.17|
CONMED Corporation has higher revenue and earnings than Orthofix International N.V.. CONMED Corporation is trading at a lower price-to-earnings ratio than Orthofix International N.V., indicating that it is currently the more affordable of the two stocks.
Orthofix International N.V. beats CONMED Corporation on 9 of the 16 factors compared between the two stocks.
About CONMED Corporation
CONMED Corporation is a medical technology company. The Company is engaged in the development, manufacturing and sale on a global basis of surgical devices and related equipment. The Company provides surgical devices and equipment for minimally invasive procedures. The Company’s products are used by surgeons and physicians in a range of specialties, including orthopedics, general surgery, gynecology, neurosurgery and gastroenterology. The Company’s product lines consist of orthopedic surgery, general surgery and surgical visualization. As of December 31, 2016, the Company’s products are distributed domestically directly to over 6,000 hospitals, surgery centers and other healthcare institutions, as well as through medical specialty distributors. The Company’s orthopedic surgery product lines include sports medicine, powered surgical instruments, and sports biologics and tissue. These products are marketed under a range of brands, including Hall, CONMED Linvatec, Concept and Shutt.
About Orthofix International N.V.
Orthofix International N.V. (Orthofix) is a global medical device company. The Company is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The company operates in four segments: BioStim, Biologics, Extremity Fixation and Spine Fixation. Its BioStim solutions products include Cervical-Stim, Spinal-Stim and Physio-Stim. The Biologics products include AlloQuent Structural Allografts, Trinity ELITE, Trinity Evolution and VersaShield. The Extremity Fixation products include Fixator, Eight-Plate Guided Growth System and Contours VPS Volar Plating System III. The Spine Fixation products include Hallmark Anterior Cervical Plate System, Ascent LE Posterior Occipital Cervico-Thoracic (POCT) System, Firebird Deformity Correction System, Phoenix Minimally Invasive Spinal Fixation System, Samba-Screw System, LONESTAR Cervical Stand Alone (CSA), SKYHAWK Lateral Interbody Fusion System & Lateral Plate System and CENTURION POCT System.
Receive News & Ratings for CONMED Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CONMED Corporation and related companies with our FREE daily email newsletter.